Accounts receivable, net of credit losses of december 31, 2024 14,281 (0 as of december 31, 2023)
40
Total current assets
761
Equity investees
0
Intangible assets, net
0
Other assets
0
Goodwill
0
Operating lease right-of-use assets
0
Deposits
12
Subtotal
13,164
Less accumulated depreciation
12,586
Property, plants and equipment, net
578
Total non-current assets
590
Total assets
1,351
Short-term bank credit
40
Accounts payable-Nonrelated Party
10,428
Accounts payable-Related Party
2,695
Accrued expenses and other payables
2,345
Income tax payable
781
Employees and related payables
2,122
Advance payments on account of grant
72
Short-term loans
6,183
Current maturities of finance leases
25
Current maturities of operating leases
234
Short-term and current maturities of convertible loans
1,995
Total current liabilities
26,920
Non-current operating leases
1,308
Loans payable
2,895
Convertible loans
5,578
Finance leases
1
Other long-term liabilities
2,182
Total long-term liabilities
11,964
Total liabilities
38,884
Common stock of 0.0001 par value authorized at december 31, 2024 and december 31, 2023 14,583,333 shares issued at december 31, 2024 and december 31, 2023 5,199,963 and 3,216,363 shares, respectively outstanding at december 31, 2024 and december 31, 2023 5,171,306 and 3,187,706 shares, respectively
5
Additional paid-in capital
188,163
Accumulated other comprehensive income
384
Treasury stock 286,567 shares as of december 31, 2024 and december 31, 2023
1,266
Accumulated deficit
-224,787
Equity attributable to orgenesis inc
-37,501
Non-controlling interests
-32
Total equity (capital deficiency)
-37,533
Total liabilities, redeemable non-controlling interest and equity (capital deficiency)
1,351
Unit: Thousand (K) dollars (except for numbers of shares and EPS).
Time Plot
Show the time plot by selecting a row from the table.